Related Experiment Video
Updated: Mar 13, 2026
10:21
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
941
[Research progress of serrated polyposis syndrome]
1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China. hychenjs@126.com.
Summary
Serrated polyposis syndrome (SPS) significantly increases colorectal cancer risk, with diagnosis requiring specific serrated polyp counts and characteristics. Early detection and resection are crucial for managing this condition.
Area of Science:
- Gastroenterology
- Oncology
- Genetics
Background:
- Serrated polyposis syndrome (SPS) is linked to colorectal cancer (CRC) development.
- Research on SPS in China is limited, highlighting a knowledge gap.
- Serrated polyps, including hyperplastic, sessile serrated, and traditional serrated types, are key to SPS diagnosis.
Purpose of the Study:
- To summarize diagnostic criteria for SPS.
- To outline the association between SPS and colorectal cancer risk.
- To discuss current detection methods and management recommendations for SPS.
Main Methods:
- Review of diagnostic standards for SPS based on serrated polyp number, size, and location.
- Analysis of clinical characteristics, including age, family history, and genetic mutations (BRAF, KRAS).
- Evaluation of detection technologies like auto-fluorescence imaging (AFI) and narrow-band imaging (NBI).
Main Results:
- SPS diagnosis involves specific criteria: ≥5 serrated lesions in the proximal colon (≥2 >10mm), or 1 serrated polyp with family history, or >20 serrated polyps in the entire colon.
- SPS patients face a high risk of synchronous or metachronous CRC (25%-70%).
- Common findings in SPS include BRAF/KRAS mutations, CpG island methylation phenotype (CIMP), and microsatellite instability (MSI).
Conclusions:
- SPS requires careful differentiation from familial adenomatous polyposis (FAP) due to distinct mechanisms and malignancy risks.
- Current detection rates for serrated polyps using AFI and NBI are approximately 55%.
- Management involves resecting serrated polyps >3-5mm and regular colonoscopic surveillance; further research into molecular mechanisms and precise cancer risk is needed.
